{"nct_id":"NCT02935686","title":"A Safety, Tolerability and Immunogenicity Study of 2 Different Regimens of Tetravalent Ad26.Mos4.HIV Prime Followed by Boost With Tetravalent Ad26.Mos4.HIV Along With Either Clade C gp140 Plus Adjuvant OR With a Combination of Mosaic and Clade C gp140 Plus Adjuvant in Healthy HIV Uninfected Adults","status":"COMPLETED","status_verified_date":"2025-05","start_date":"2017-03-31","start_date_type":"ACTUAL","primary_completion_date":"2023-11-22","primary_completion_date_type":"ACTUAL","completion_date":"2023-11-22","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["JNJ"]}